CN114134128A - 一种基于祖先序列重建的ω-转氨酶突变体 - Google Patents
一种基于祖先序列重建的ω-转氨酶突变体 Download PDFInfo
- Publication number
- CN114134128A CN114134128A CN202111482472.1A CN202111482472A CN114134128A CN 114134128 A CN114134128 A CN 114134128A CN 202111482472 A CN202111482472 A CN 202111482472A CN 114134128 A CN114134128 A CN 114134128A
- Authority
- CN
- China
- Prior art keywords
- val
- gly
- leu
- ala
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465318 Aspergillus terreus Species 0.000 claims abstract description 33
- 230000035772 mutation Effects 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 12
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 9
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 239000013613 expression plasmid Substances 0.000 claims description 4
- 229940107700 pyruvic acid Drugs 0.000 claims description 4
- 238000003259 recombinant expression Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000005891 transamination reaction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 74
- 108090000790 Enzymes Proteins 0.000 abstract description 74
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 33
- 230000000694 effects Effects 0.000 description 29
- 239000000243 solution Substances 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 15
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 11
- 150000001413 amino acids Chemical group 0.000 description 10
- 108010047857 aspartylglycine Proteins 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 229940076788 pyruvate Drugs 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 7
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 7
- 229960001327 pyridoxal phosphate Drugs 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- 239000011534 wash buffer Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108010027345 wheylin-1 peptide Proteins 0.000 description 6
- KLSOMAFWRISSNI-OSUNSFLBSA-N Pro-Ile-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 KLSOMAFWRISSNI-OSUNSFLBSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 3
- GNYUVVJYGJFKHN-RVMXOQNASA-N Arg-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GNYUVVJYGJFKHN-RVMXOQNASA-N 0.000 description 3
- YKZJPIPFKGYHKY-DCAQKATOSA-N Arg-Leu-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKZJPIPFKGYHKY-DCAQKATOSA-N 0.000 description 3
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 3
- VILLWIDTHYPSLC-PEFMBERDSA-N Asp-Glu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VILLWIDTHYPSLC-PEFMBERDSA-N 0.000 description 3
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 3
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 3
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 3
- QPDUWAUSSWGJSB-NGZCFLSTSA-N Asp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N QPDUWAUSSWGJSB-NGZCFLSTSA-N 0.000 description 3
- DCWNCMRZIZSZBL-KKUMJFAQSA-N Gln-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)N)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O DCWNCMRZIZSZBL-KKUMJFAQSA-N 0.000 description 3
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 3
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 3
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 3
- YYPFZVIXAVDHIK-IUCAKERBSA-N Gly-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN YYPFZVIXAVDHIK-IUCAKERBSA-N 0.000 description 3
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 3
- ZOTGXWMKUFSKEU-QXEWZRGKSA-N Gly-Ile-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O ZOTGXWMKUFSKEU-QXEWZRGKSA-N 0.000 description 3
- MXIULRKNFSCJHT-STQMWFEESA-N Gly-Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 MXIULRKNFSCJHT-STQMWFEESA-N 0.000 description 3
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 3
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 3
- LPBWRHRHEIYAIP-KKUMJFAQSA-N His-Tyr-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LPBWRHRHEIYAIP-KKUMJFAQSA-N 0.000 description 3
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 3
- PJYSOYLLTJKZHC-GUBZILKMSA-N Leu-Asp-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(N)=O PJYSOYLLTJKZHC-GUBZILKMSA-N 0.000 description 3
- YSKSXVKQLLBVEX-SZMVWBNQSA-N Leu-Gln-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 YSKSXVKQLLBVEX-SZMVWBNQSA-N 0.000 description 3
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 3
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 3
- HGLKOTPFWOMPOB-MEYUZBJRSA-N Leu-Thr-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HGLKOTPFWOMPOB-MEYUZBJRSA-N 0.000 description 3
- BGGTYDNTOYRTTR-MEYUZBJRSA-N Leu-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(C)C)N)O BGGTYDNTOYRTTR-MEYUZBJRSA-N 0.000 description 3
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 3
- DTUZCYRNEJDKSR-NHCYSSNCSA-N Lys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN DTUZCYRNEJDKSR-NHCYSSNCSA-N 0.000 description 3
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 3
- CEGVMWAVGBRVFS-XGEHTFHBSA-N Met-Cys-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CEGVMWAVGBRVFS-XGEHTFHBSA-N 0.000 description 3
- OGAZPKJHHZPYFK-GARJFASQSA-N Met-Glu-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGAZPKJHHZPYFK-GARJFASQSA-N 0.000 description 3
- KIEPQOIQHFKQLK-PCBIJLKTSA-N Phe-Asn-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KIEPQOIQHFKQLK-PCBIJLKTSA-N 0.000 description 3
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 3
- JARJPEMLQAWNBR-GUBZILKMSA-N Pro-Asp-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JARJPEMLQAWNBR-GUBZILKMSA-N 0.000 description 3
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 3
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 3
- 108090000340 Transaminases Proteins 0.000 description 3
- FOAJSVIXYCLTSC-PJODQICGSA-N Trp-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N FOAJSVIXYCLTSC-PJODQICGSA-N 0.000 description 3
- LNGFWVPNKLWATF-ZVZYQTTQSA-N Trp-Val-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LNGFWVPNKLWATF-ZVZYQTTQSA-N 0.000 description 3
- FWOVTJKVUCGVND-UFYCRDLUSA-N Tyr-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FWOVTJKVUCGVND-UFYCRDLUSA-N 0.000 description 3
- RCMWNNJFKNDKQR-UFYCRDLUSA-N Tyr-Pro-Phe Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 RCMWNNJFKNDKQR-UFYCRDLUSA-N 0.000 description 3
- XXWBHOWRARMUOC-NHCYSSNCSA-N Val-Lys-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O)N XXWBHOWRARMUOC-NHCYSSNCSA-N 0.000 description 3
- LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 3
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 3
- QSPOLEBZTMESFY-SRVKXCTJSA-N Val-Pro-Val Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O QSPOLEBZTMESFY-SRVKXCTJSA-N 0.000 description 3
- SUGRIIAOLCDLBD-ZOBUZTSGSA-N Val-Trp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SUGRIIAOLCDLBD-ZOBUZTSGSA-N 0.000 description 3
- KJFBXCFOPAKPTM-BZSNNMDCSA-N Val-Trp-Val Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O)=CNC2=C1 KJFBXCFOPAKPTM-BZSNNMDCSA-N 0.000 description 3
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 3
- 108010047495 alanylglycine Proteins 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 3
- 108010054813 diprotin B Proteins 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 108010078144 glutaminyl-glycine Proteins 0.000 description 3
- 108010081551 glycylphenylalanine Proteins 0.000 description 3
- 108010078274 isoleucylvaline Proteins 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 108010012058 leucyltyrosine Proteins 0.000 description 3
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108010074082 phenylalanyl-alanyl-lysine Proteins 0.000 description 3
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 108010031719 prolyl-serine Proteins 0.000 description 3
- 108010090894 prolylleucine Proteins 0.000 description 3
- 239000012474 protein marker Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 108010038745 tryptophylglycine Proteins 0.000 description 3
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 2
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 2
- NPAVRDPEFVKELR-DCAQKATOSA-N Arg-Lys-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NPAVRDPEFVKELR-DCAQKATOSA-N 0.000 description 2
- UZSQXCMNUPKLCC-FJXKBIBVSA-N Arg-Thr-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UZSQXCMNUPKLCC-FJXKBIBVSA-N 0.000 description 2
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 2
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 2
- WSXDIZFNQYTUJB-SRVKXCTJSA-N Asp-His-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O WSXDIZFNQYTUJB-SRVKXCTJSA-N 0.000 description 2
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 2
- FTIJVMLAGRAYMJ-MNXVOIDGSA-N Gln-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(N)=O FTIJVMLAGRAYMJ-MNXVOIDGSA-N 0.000 description 2
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 2
- HILMIYALTUQTRC-XVKPBYJWSA-N Glu-Gly-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HILMIYALTUQTRC-XVKPBYJWSA-N 0.000 description 2
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 2
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 2
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 2
- NWOSHVVPKDQKKT-RYUDHWBXSA-N Gly-Tyr-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O NWOSHVVPKDQKKT-RYUDHWBXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- HIAHVKLTHNOENC-HGNGGELXSA-N His-Glu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HIAHVKLTHNOENC-HGNGGELXSA-N 0.000 description 2
- WUKLZPHVWAMZQV-UKJIMTQDSA-N Ile-Glu-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N WUKLZPHVWAMZQV-UKJIMTQDSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 2
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 2
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 2
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 2
- VKCPHIOZDWUFSW-ONGXEEELSA-N Lys-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN VKCPHIOZDWUFSW-ONGXEEELSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- VZBXCMCHIHEPBL-SRVKXCTJSA-N Met-Glu-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN VZBXCMCHIHEPBL-SRVKXCTJSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- LCRSGSIRKLXZMZ-BPNCWPANSA-N Pro-Ala-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LCRSGSIRKLXZMZ-BPNCWPANSA-N 0.000 description 2
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 2
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 2
- CNIIKZQXBBQHCX-FXQIFTODSA-N Ser-Asp-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O CNIIKZQXBBQHCX-FXQIFTODSA-N 0.000 description 2
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 2
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 2
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 2
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 2
- TWLMXDWFVNEFFK-FJXKBIBVSA-N Thr-Arg-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O TWLMXDWFVNEFFK-FJXKBIBVSA-N 0.000 description 2
- CWQZAUYFWRLITN-AVGNSLFASA-N Tyr-Gln-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N)O CWQZAUYFWRLITN-AVGNSLFASA-N 0.000 description 2
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 2
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 2
- COYSIHFOCOMGCF-WPRPVWTQSA-N Val-Arg-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-WPRPVWTQSA-N 0.000 description 2
- ZSZFTYVFQLUWBF-QXEWZRGKSA-N Val-Asp-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N ZSZFTYVFQLUWBF-QXEWZRGKSA-N 0.000 description 2
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 2
- LKUDRJSNRWVGMS-QSFUFRPTSA-N Val-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LKUDRJSNRWVGMS-QSFUFRPTSA-N 0.000 description 2
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 102000006635 beta-lactamase Human genes 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- QRIYOHQJRDHFKF-UWJYBYFXSA-N Ala-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 QRIYOHQJRDHFKF-UWJYBYFXSA-N 0.000 description 1
- RWCLSUOSKWTXLA-FXQIFTODSA-N Arg-Asp-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RWCLSUOSKWTXLA-FXQIFTODSA-N 0.000 description 1
- KRQSPVKUISQQFS-FJXKBIBVSA-N Arg-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N KRQSPVKUISQQFS-FJXKBIBVSA-N 0.000 description 1
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 1
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- SLHOOKXYTYAJGQ-XVYDVKMFSA-N Asp-Ala-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 SLHOOKXYTYAJGQ-XVYDVKMFSA-N 0.000 description 1
- ZSJFGGSPCCHMNE-LAEOZQHASA-N Asp-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N ZSJFGGSPCCHMNE-LAEOZQHASA-N 0.000 description 1
- TVIZQBFURPLQDV-DJFWLOJKSA-N Asp-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N TVIZQBFURPLQDV-DJFWLOJKSA-N 0.000 description 1
- KYQNAIMCTRZLNP-QSFUFRPTSA-N Asp-Ile-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O KYQNAIMCTRZLNP-QSFUFRPTSA-N 0.000 description 1
- HSGOFISJLFDMBJ-CIUDSAMLSA-N Asp-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N HSGOFISJLFDMBJ-CIUDSAMLSA-N 0.000 description 1
- NJLLRXWFPQQPHV-SRVKXCTJSA-N Asp-Tyr-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJLLRXWFPQQPHV-SRVKXCTJSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- DCJNIJAWIRPPBB-CIUDSAMLSA-N Cys-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N DCJNIJAWIRPPBB-CIUDSAMLSA-N 0.000 description 1
- WZJLBUPPZRZNTO-CIUDSAMLSA-N Cys-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N WZJLBUPPZRZNTO-CIUDSAMLSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- ORYMMTRPKVTGSJ-XVKPBYJWSA-N Gln-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O ORYMMTRPKVTGSJ-XVKPBYJWSA-N 0.000 description 1
- CVPXINNKRTZBMO-CIUDSAMLSA-N Glu-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)CN=C(N)N CVPXINNKRTZBMO-CIUDSAMLSA-N 0.000 description 1
- ZQYZDDXTNQXUJH-CIUDSAMLSA-N Glu-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)N ZQYZDDXTNQXUJH-CIUDSAMLSA-N 0.000 description 1
- XNOWYPDMSLSRKP-GUBZILKMSA-N Glu-Met-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(O)=O XNOWYPDMSLSRKP-GUBZILKMSA-N 0.000 description 1
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 1
- QPTNELDXWKRIFX-YFKPBYRVSA-N Gly-Gly-Gln Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O QPTNELDXWKRIFX-YFKPBYRVSA-N 0.000 description 1
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001575999 Hakka Species 0.000 description 1
- 101001009859 Herpetosiphon aurantiacus (strain ATCC 23779 / DSM 785 / 114-95) (+)-kolavenyl diphosphate synthase Proteins 0.000 description 1
- GQKSJYINYYWPMR-NGZCFLSTSA-N Ile-Gly-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N GQKSJYINYYWPMR-NGZCFLSTSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- QGXQHJQPAPMACW-PPCPHDFISA-N Ile-Thr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QGXQHJQPAPMACW-PPCPHDFISA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- QUAAUWNLWMLERT-IHRRRGAJSA-N Leu-Arg-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O QUAAUWNLWMLERT-IHRRRGAJSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- JKSIBWITFMQTOA-XUXIUFHCSA-N Leu-Ile-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O JKSIBWITFMQTOA-XUXIUFHCSA-N 0.000 description 1
- LVTJJOJKDCVZGP-QWRGUYRKSA-N Leu-Lys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LVTJJOJKDCVZGP-QWRGUYRKSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 1
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 1
- YVMQJGWLHRWMDF-MNXVOIDGSA-N Lys-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N YVMQJGWLHRWMDF-MNXVOIDGSA-N 0.000 description 1
- GFWLIJDQILOEPP-HSCHXYMDSA-N Lys-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N GFWLIJDQILOEPP-HSCHXYMDSA-N 0.000 description 1
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 1
- YDDDRTIPNTWGIG-SRVKXCTJSA-N Lys-Lys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O YDDDRTIPNTWGIG-SRVKXCTJSA-N 0.000 description 1
- SBQDRNOLGSYHQA-YUMQZZPRSA-N Lys-Ser-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SBQDRNOLGSYHQA-YUMQZZPRSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 1
- WGBMNLCRYKSWAR-DCAQKATOSA-N Met-Asp-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN WGBMNLCRYKSWAR-DCAQKATOSA-N 0.000 description 1
- BJPQKNHZHUCQNQ-SRVKXCTJSA-N Met-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)N BJPQKNHZHUCQNQ-SRVKXCTJSA-N 0.000 description 1
- YGNUDKAPJARTEM-GUBZILKMSA-N Met-Val-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O YGNUDKAPJARTEM-GUBZILKMSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 101710164401 Omega-aminotransferase Proteins 0.000 description 1
- MGECUMGTSHYHEJ-QEWYBTABSA-N Phe-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGECUMGTSHYHEJ-QEWYBTABSA-N 0.000 description 1
- YUPRIZTWANWWHK-DZKIICNBSA-N Phe-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N YUPRIZTWANWWHK-DZKIICNBSA-N 0.000 description 1
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 1
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 1
- FRKBNXCFJBPJOL-GUBZILKMSA-N Pro-Glu-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FRKBNXCFJBPJOL-GUBZILKMSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- MPPHJZYXDVDGOF-BWBBJGPYSA-N Ser-Cys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CO MPPHJZYXDVDGOF-BWBBJGPYSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 1
- RRRRCRYTLZVCEN-HJGDQZAQSA-N Thr-Leu-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O RRRRCRYTLZVCEN-HJGDQZAQSA-N 0.000 description 1
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 1
- SEFNTZYRPGBDCY-IHRRRGAJSA-N Tyr-Arg-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N)O SEFNTZYRPGBDCY-IHRRRGAJSA-N 0.000 description 1
- FOADDSDHGRFUOC-DZKIICNBSA-N Val-Glu-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N FOADDSDHGRFUOC-DZKIICNBSA-N 0.000 description 1
- 241001400064 Valeria Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- -1 amine compound Chemical class 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000003367 kinetic assay Methods 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- OCQZXMCGTAWGEQ-UHFFFAOYSA-N prop-2-enamide;n-[(prop-2-enoylamino)methyl]prop-2-enamide Chemical compound NC(=O)C=C.C=CC(=O)NCNC(=O)C=C OCQZXMCGTAWGEQ-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
- 229960004034 sitagliptin Drugs 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种基于祖先序列重建的ω‑转氨酶突变体,涉及分子生物学技术领域。由来自土曲霉(Aspergillus terreus)的ω‑转氨酶突变所得,所述ω‑转氨酶突变体的氨基酸序列如SEQ ID NO.4或SEQ ID NO.6所示。与野生型酶相比,ω‑转氨酶突变体的半衰期均在24h以上,而野生型仅为6.90min,突变体的半失活温度分别为49.00℃和49.03℃,比野生型(37.89℃)提高了约11℃,热稳定性显著提高。
Description
技术领域
本发明涉及分子生物学技术领域,具体涉及一种基于祖先序列重建的ω-转氨酶突变体。
背景技术
手性胺是指小分子化合物手性中心含有氨基的一类化合物,是一类重要的药物合成中间体。近年来,随着手性药物市场不断扩大,手性胺及其衍生物占据手性药物的份额超过70%,如神经类药物、心血管药物、抗高血压药物、抗感染药物及疫苗等;抗糖尿病药物的主要成分西他列汀就是R-型胺。市场对手性胺药物的需求巨大,使得高效制备手性胺药物极为重要。
转氨酶是生物法制备手性胺的关键酶,它能够可逆催化酮基与氨基之间的氨基转移反应以合成胺类化合物。来自于土曲霉(Aspergillus terreus)的ω-转氨酶以磷酸吡哆醛(pyridoxal phosphate,PLP)为辅酶,催化氨基供体上的氨基转移到具有手性的受体酮上,生成手性胺和副产物酮,催化过程如下所示:
虽然转氨酶在合成手性胺方面有较好的应用前景,但野生型酶在底物特异性、稳定性、催化效率等方面还存在诸多不足,不利于将其应用到工业生产中。来源于土曲霉(Aspergillus terreus)的野生型ω-转氨酶在40℃下的半衰期仅为6.90min,需对其进行热稳定性改造。申请号为CN105441404A、CN105950581A的申请专利利用定点突变技术对ω-转氨酶野生型进行改造,获得了热稳定性进一步提高的ω-转氨酶突变体。而随着计算机技术的不断发展,通过祖先序列重建技术获得热稳定性较好的祖先酶也已成为研究热点。
祖先序列重建(Ancestral sequence reconstruction,ASR)是指通过计算机算法推导灭绝生物的祖先酶氨基酸序列的技术。基于前寒武纪时期地球环境极端,如高温且原始细胞仅依耐少数酶系的假设,一般认为祖先酶通常具有更好的热稳定性。因而利用祖先序列重建技术获得现有酶的祖先酶也成为一种提高酶的热稳定性、活性的方法,如Hendrikse等(Yosephin Gumulya,et al.Engineering highly functional thermostableproteins using ancestral sequence reconstruction.Nature Catalysis,2018,1(11):878-888.)利用祖先酶序列重建技术提高了细菌二萜类环化酶的稳定性、活性;RissoValeria等(Risso Valeria A,et al.Hyperstability and substrate promiscuity inlaboratory resurrections of Precambrianβ-lactamases.Journal of the AmericanChemical Society,2013,135(8):2899-902.)通过ASR技术获得了比现有酶更耐热的β-内酰胺酶。
目前尚无利用祖先序列重建技术获得现有酶的祖先酶的方法来提高土曲霉(Aspergillus terreus)ω-转氨酶热稳定性的相关研究报道。
发明内容
本发明基于利用祖先序列重建技术获得现有酶的祖先酶的方法,通过该方法获得酶活、热稳定性进一步提高的土曲霉(Aspergillus terreus)ω-转氨酶突变体。
本发明将土曲霉(Aspergillus terreus)ω-转氨酶的蛋白质序列上传至FireProtASR(https://loschmidt.chemi.muni.cz/fireprotasr/,一个全自动祖先序列重建的服务器),通过该网站全自动分析获得了土曲霉ω-转氨酶的系统进化树,然后选定进化树上最终进化为土曲霉ω-转氨酶这一分支的各个节点,并从该网站下载这些节点对应的基因序列,然后全基合成得到相应的突变后基因序列。经过酶的表达纯化和热稳定性检测,最终获得了热稳定性显著提高的两个突变体:
突变体1,命名为Ancata-101:
D5E-A12Q-I17V-S20A-T21S-E22A-T23S-A42H-I77L-T78S-T85S-L87M-R90K-D96E-Q97E-E104D-T130S-R131K-D134E-I135L-138insN-V143I-D153E-V157T-V162I-V163I-A174S-I175M-V188T-A195S-H210N-Q236E-N245D-A246V-E248R-F250N-F258V-R266Q-T284S-M288K-G292D-Q294K-I295V-A313P-N322E-E323S-R324A-N325S-325insKKSG;
突变体2,命名为Ancata-124:
D5E-A12Q-I17V-S20A-T21S-E22A-T23S-A42H-I77L-T78S-T85A-R90K-D96E-Q97E-E104D-T130S-R130K-I135L-138insN-V143I-D153E-M154V-V157T-V162I-V163I-A195S-H210N-Q236E-N245D-A246V-E248R-F250N-F258V-L263M-R266Q-T284S-M288K-G292D-Q294K-I295V-A313P-N322E-E323S-R324A-N325S-325insKS,
其中,138insN意为在野生型酶氨基酸序列的138号位点后面插入(insert)N(天冬酰胺);325insKKSG意为在野生型酶氨基酸序列的325号位点后面插入(insert)KKSG(K:赖氨酸,S:丝氨酸,G:甘氨酸);325insKS意为在野生型酶氨基酸序列的325号位点后面插入(insert)KS。
本发明提供了一种基于祖先序列重建的ω-转氨酶突变体,由来自土曲霉(Aspergillus terreus)的ω-转氨酶突变所得,野生型ω-转氨酶的氨基酸序列如SEQ IDNo.2所示,所述ω-转氨酶突变体的氨基酸序列如SEQ ID NO.4或SEQ ID NO.6所示。
本发明又提供了所述ω-转氨酶突变体在催化(R)-(+)-α-甲基苄胺生成苯乙酮中的应用。相较于野生型酶,突变体酶在较高温条件下具有较好的热力学稳定性,更适合工业应用。
本发明又提供了编码所述ω-转氨酶突变体的基因。
优选的,两种ω-转氨酶突变体的基因序列为SEQ ID NO.3或SEQ ID NO.5所示。
本发明又提供了所述基因在催化(R)-(+)-α-甲基苄胺生成苯乙酮中的应用。
本发明还提供了包含上述基因的重组表达质粒。
本发明还提供了包含上述重组表达质粒的基因工程菌。
本发明还提供了上述基因工程菌在催化(R)-(+)-α-甲基苄胺生成苯乙酮中的应用。
本发明还提供了一种催化(R)-(+)-α-甲基苄胺生成苯乙酮的方法,以(R)-(+)-α-甲基苄胺和丙酮酸作为底物,使用上述ω-转氨酶突变体或上述基因工程菌进行催化发生转氨反应,生成苯乙酮。
与现有技术相比,本发明具有以下有益效果:
(1)与野生型酶相比,ω-转氨酶突变体的半衰期均在24h以上,而野生型仅为6.90min,突变体的半失活温度分别为49.00℃和49.03℃,比野生型(37.89℃)提高了约11℃,热稳定性显著提高。
(2)利用祖先序列重建技术,筛选获得热力学稳定性、酶活性方面明显优于野生酶的ω-转氨酶突变体。
附图说明
图1为野生型和突变体的SDS-PAGE电泳分析结果图;其中,各泳道分别为M:protein marker;1:野生型酶液(未纯化);2:野生型酶液(纯化);3:突变体Ancata-101酶液(纯化);4:突变体Ancata-124酶液(纯化)。
图2为野生型ω-转氨酶和ω-转氨酶突变体酶的酶活力检测结果图;其中,a为比酶活,b为相对酶活。
图3为野生型ω-转氨酶和ω-转氨酶突变体酶的稳定性检测结果图;其中,a为野生型和Ancata-101、Ancata-124的T50 10;b为野生型和Ancata-101、Ancata-124在40℃、45℃和47℃下的t1/2。
具体实施方式
实施例1
来自于土曲霉(Aspergillus terreus)的野生型ω-转氨酶的氨基酸序列如SEQID No.2所示,基因序列如SEQ ID No.1所示。
将土曲霉ω-转氨酶的蛋白质序列上传至Fire ProtASR(https://loschmidt.chemi.muni.cz/fireprotasr/,一个全自动祖先序列重建的服务器),通过该网站全自动分析获得了土曲霉ω-转氨酶的系统进化树,然后选定进化树上最终进化为土曲霉ω-转氨酶这一分支的各个节点,并从该网站下载这些节点对应的基因序列,然后全基因合成得到相应的突变后基因序列。经过酶的表达纯化和热稳定性检测,最终获得了热稳定性显著提高的两个突变体,分别命名为Ancata-101和Ancata-124,突变位点和序列如下:
Ancata-101:D5E-A12Q-I17V-S20A-T21S-E22A-T23S-A42H-I77L-T78S-T85S-L87M-R90K-D96E-Q97E-E104D-T130S-R131K-D134E-I135L-138insN-V143I-D153E-V157T-V162I-V163I-A174S-I175M-V188T-A195S-H210N-Q236E-N245D-A246V-E248R-F250N-F258V-R266Q-T284S-M288K-G292D-Q294K-I295V-A313P-N322E-E323S-R324A-N325S-325insKKSG,基因序列如SEQ ID NO.3所示,氨基酸序列如SEQ ID NO.4所示;
Ancata-124:D5E-A12Q-I17V-S20A-T21S-E22A-T23S-A42H-I77L-T78S-T85A-R90K-D96E-Q97E-E104D-T130S-R130K-I135L-138insN-V143I-D153E-M154V-V157T-V162I-V163I-A195S-H210N-Q236E-N245D-A246V-E248R-F250N-F258V-L263M-R266Q-T284S-M288K-G292D-Q294K-I295V-A313P-N322E-E323S-R324A-N325S-325insKS,基因序列如SEQID NO.5所示,氨基酸序列如SEQ ID NO.6所示。
实施例2
(1)材料与试剂
(R)-ω-TA及突变体全基因由安徽通用生物公司合成,载体为pET-28a(+),表达宿主菌株为E.coli BL21(DE3);异丙基-β-D-硫代半乳糖苷(IPTG)、硫酸卡那霉素(Kanamycinsulfate)、磷酸吡哆醛(pyrodoxal-5’-phosphate,PLP)、改良型Bradford蛋白浓度测定试剂盒购自生工生物工程(上海)股份有限公司;Protein Marker、Ni-NTA层析介质购自北京全式金生物技术有限公司;十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)凝胶制备试剂盒购于康为世纪生物科技有限公司;二甲基亚砜(DMSO)、丙酮酸、(R)-α-甲基苄胺购自阿拉丁生化科技股份有限公司。
(2)酶的表达与纯化
取10μL野生型重组质粒菌液及突变体菌液分别接种于5mL含有终浓度为50μg/mLKanamycin的Luria-Bertani液体培养基(LB培养基)中,37℃、200rpm条件下摇床培养12h。菌液以2%的接种量(V/V)转接至200mL含有终浓度为50μg/mL Kanamycin的LB液体培养基中,37℃、200rpm条件下继续培养2-3h。当OD600达到0.8时,加入终浓度为0.5mM的IPTG,并在25℃、150rpm条件下诱导蛋白表达。诱导20h后,在6000rpm,4℃条件下离心收集菌体。
菌体细胞用50mM的PBS缓冲液(50mM磷酸二氢钠,50mM磷酸氢二钠,300mM氯化钠,pH为8.0)洗涤1次去除残留培养基后重悬于上述PBS缓冲液中。冰浴条件下对菌体细胞进行均质机破碎细胞。细胞破碎液在8000rpm,4℃条件下离心1h,收集得到的上清液即为含有ω-转氨酶的粗酶液。随后,将粗酶液用0.45μm滤膜过滤后采用Ni-NTA亲和层析柱分离纯化目的蛋白。
纯化缓冲液如下:
20mM咪唑清洗缓冲液:50mM磷酸二氢钠,300mM氯化钠,20mM咪唑,pH 8.0;
50mM咪唑清洗缓冲液:50mM磷酸二氢钠,300mM氯化钠,50mM咪唑,pH 8.0;
250mM咪唑洗脱缓冲液:50mM磷酸二氢钠,300mM氯化钠,250mM咪唑,pH 8.0。
具体纯化步骤:
1)平衡Ni-NTA亲和层析柱:按顺序用20%(V/V)乙醇水溶液、去离子水和20mM咪唑清洗缓冲液各洗3个柱体积;
2)上样:注射器取粗酶液经0.45μm滤膜过滤,带有6个组氨酸标签的目的蛋白能与填料结合。
3)清洗:20mM咪唑清洗缓冲液和50mM咪唑清洗缓冲液各洗3柱体积,Bradford溶液检测是否洗干净杂蛋白;
4)洗脱:250mM咪唑洗脱缓冲液冲洗,收集5mL穿流液。
5)保存柱子:按顺序用20mM咪唑清洗缓冲液、去离子水和20%(V/V)乙醇水溶液各洗3个柱体积,最后保存于20%(V/V)乙醇水溶液中。
(3)蛋白含量的测定。
采用改良型Bradford蛋白浓度测定试剂盒建立蛋白含量标准曲线,测定实施例2中步骤(2)得到的纯酶的浓度,蛋白标准曲线的制备步骤参照说明书进行。采用SDS-PAGE方法鉴定纯化后蛋白的分子量和纯度。具体步骤如下:
制胶:12%分离胶,5%浓缩胶。配方如表1所示。
表1 SDS-PAGE蛋白电泳分离胶和浓缩胶配方
注:Acr-Bis:Acrylamide-Bisacrylamide,丙烯酰胺/亚甲基双丙烯酰胺;
TEMED:N,N,N',N'-Tetramethylethylenediamine,四甲基乙二胺。
样品处理:酶液40μL与5×蛋白加样缓冲液10μL混匀,沸水浴10min。
上样:蛋白Marker 10μL,样品15μL。
电泳条件:电压120V,电泳约90min,待溴酚蓝指示剂移至距凝胶下端边缘约1cm处停止电泳。
染色:染色液没过凝胶,微波炉加热1min,于摇床染色25min。
脱色:回收染色液,换上脱色液,每小时换一次脱色液,至蛋白条带清晰。
蛋白含量测定:将目的蛋白稀释到BSA标准曲线的线性范围内,通过酶标仪测定A595值,求得稀释后的蛋白浓度。
野生型和突变体的SDS-PAGE电泳图谱如图1所示。野生型和突变体的电泳条带位于同一位置,且与理论分子量36.1kDa一致,为后续实验奠定了基础。
(4)酶活力的测定
1)酶活力的测定
20μL纯酶与180μL底物溶液(10mM PLP,2.5mM(R)-α-MBA((R)-(+)-α-甲基苄胺),2.5mM丙酮酸,0.25%DMSO,50mM PBS,pH8.0)于25℃条件下反应3min,测定OD245苯乙酮的生成量,具体方法参考文献(Rapid and sensitive kinetic assay for characterizationofω-transaminases.Anal Chem,2009,81:8244-8248.)。酶活力(U)定义为在一定条件下,每分钟转氨酶催化底物丙酮酸和(R)-α-MBA发生转氨反应生成1μmoL苯乙酮所需酶量。
野生型和2个突变体的酶活力如图2(a)所示,与ω-转氨酶野生型的酶活力相比,2个突变体的的酶活力显著提高,分别是野生型酶活力的1.67倍和1.46倍。
2)酶残余活力的测定
将纯化的野生型和突变体在40℃下孵育10min,孵育结束后,立即放冰上冷却10min。随后,20μL经热处理的酶液与180μL底物溶液(10mM PLP,2.5mM(R)-α-MBA,2.5mM丙酮酸,0.25%DMSO,50mM PBS,pH 8.0)于25℃条件下反应3min,测定野生型和突变体的残余活力。实验平行三次,以未经40℃下孵育处理的野生型酶活力为100%,筛选出相对酶活力比野生型高的突变体。40℃下热处理10min后,野生型和2个突变体的残余活力如图2(b)所示。突变体Ancata-101、Ancata-124的活力基本未下降,而野生型的活力下降了约60%。
综上所述,利用祖先序列重建方法,筛选到2个热稳定性均显著提升的突变体Ancata-101(D5E-A12Q-I17V-S20A-T21S-E22A-T23S-A42H-I77L-T78S-T85S-L87M-R90K-D96E-Q97E-E104D-T130S-R131K-D134E-I135L-138insN-V143I-D153E-V157T-V162I-V163I-A174S-I175M-V188T-A195S-H210N-Q236E-N245D-A246V-E248R-F250N-F258V-R266Q-T284S-M288K-G292D-Q294K-I295V-A313P-N322E-E323S-R324A-N325S-325insKKSG,基因序列如SEQ ID NO.3所示,氨基酸序列如SEQ ID NO.4所示)、Ancata-124(D5E-A12Q-I17V-S20A-T21S-E22A-T23S-A42H-I77L-T78S-T85A-R90K-D96E-Q97E-E104D-T130S-R130K-I135L-138insN-V143I-D153E-M154V-V157T-V162I-V163I-A195S-H210N-Q236E-N245D-A246V-E248R-F250N-F258V-L263M-R266Q-T284S-M288K-G292D-Q294K-I295V-A313P-N322E-E323S-R324A-N325S-325insKS,基因序列如SEQ ID NO.5所示,氨基酸序列如SEQ ID NO.6所示)。
(5)酶动力学参数的测定
用含0.01mM PLP的PBS缓冲液(50mM,pH 8.0)分别配制0、0.125、0.25、0.5、1.0、1.5、2.0、2.5、3.0mM不同浓度的(R)-α-MBA和丙酮酸底物溶液。采用酶活力测定的方法测定在不同浓度下ω-转氨酶野生型和突变体的酶活力。将不同底物以及不同底物浓度[S]下对应的反应速率V带入米氏方程V=Vmax×[S]/(Km+[S]),利用Origin 8.0软件进行非线性拟合,并计算野生型和突变体对应的酶动力学参数Km和Vmax;由公式kcat=Vmax/[E]计算野生型和突变体对应的转化数kcat和催化效率kcat/Km,其中[E]为酶的摩尔浓度。结果如表2所示,两种突变酶对丙酮酸的转化数提升幅度低于亲和力的提升幅度,比野生型对丙酮酸的催化效率要低。突变酶Ancata-101和Ancata-124的Km α-MBA值都为0.28mM,略高于野生型,但前者的kcat α-MBA值是野生型的1.67倍,而后者kcat α-MBA值略低于野生型,计算得到Ancata-101和Ancata-124的kcat/Km α-MBA分别为3.81s-1·mM-1和2.07s-1·mM-1,前者对α-MBA的催化效率为野生型的1.35倍,略有提升,而后者低于野生型。综上所述,两种突变体的催化效率并未得到显著提升。
表2野生型和突变体的动力学参数
名称 | WT-AT | Ancata-101 | Ancata-124 |
k<sub>cat</sub><sup>pyruvate</sup>(s<sup>-1</sup>) | 0.50±0.01 | 1.50±0.03 | 0.74±0.03 |
K<sub>m</sub><sup>pyruvate</sup>(mM) | 0.23±0.02 | 1.15±0.02 | 0.93±0.01 |
k<sub>cat</sub>/K<sub>m</sub><sup>pyruvate</sup>(L/(s·mmol)) | 2.22 | 1.30 | 0.79 |
k<sub>cat</sub><sup>α-MBA</sup>(s<sup>-1</sup>) | 0.64±0.01 | 1.07±0.02 | 0.60±0.01 |
K<sub>m</sub><sup>α-MBA</sup>(mM) | 0.23±0.03 | 0.28±0.03 | 0.28±0.01 |
k<sub>cat</sub>/K<sub>m</sub><sup>α-MBA</sup>(L/(s·mmol)) | 2.82 | 3.81 | 2.07 |
(6)热稳定性的测定。
1)T50 10的测定
T50 10是指纯酶在4-60℃下孵育10min后,酶残余活力降低到50%时所对应的温度。将纯化后的野生酶及其突变体分别在4℃、25℃、30℃、35℃、40℃、45℃、47℃、49℃、50℃和55℃下孵育10min,孵育结束后迅速放置冰上冷却10min,测定野生型及其突变体的残余活力。以温度为横坐标,以热处理后与未经热处理的酶活力比值为纵坐标,运用Origin8.0软件作图,计算野生型和突变体的T50 10。
2)t1/2的测定
t1/2是指纯酶在40℃下孵育不同时间后,酶残余活力降低到50%时所对应的时间。将纯化后的野生型及其突变体分别在40℃下孵育0-24h,孵育结束后立即放冰上冷却10min,测定野生型及其突变体的残余活力。以时间为横坐标,以热处理后与未经热处理的酶活力比值为纵坐标,运用Origin 8.0软件作图,计算野生型和突变体在40℃下的t1/2。
表3野生型和突变体的稳定性参数
名称 | WT-AT | Ancata-101 | Ancata-124 |
T<sub>50</sub><sup>10</sup>(℃) | 37.89±0.5 | 49.00±0.4 | 49.03±0.5 |
T<sub>50</sub><sup>10</sup>提高温度(℃) | - | 11.11 | 11.14 |
t<sub>1/2</sub>(min) | 6.90±0.6 | >1440 | >1440 |
t<sub>1/2</sub>提升的倍数 | - | 207 | 207 |
突变体Ancata-101、Ancata-124的稳定性测定结果如图3和表3所示。野生型的T50 10为37.89℃,突变体Ancata-101、Ancata-124的T50 10分别为49.00℃和49.03℃,分别比野生型提高了11.11℃和11.14℃。突变体Ancata-101、Ancata-124的t1/2均大于24h(1440min),而野生型t1/2仅6.90min。在45℃时,野生型酶孵育不到一分钟残余活力就降低到50%,而两个突变体孵育6h以上残余活力仍大于50%。
序列表
<110> 浙江科技学院
<120> 一种基于祖先序列重建的ω-转氨酶突变体
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 978
<212> DNA
<213> 土曲霉(Aspergillus terreus)
<400> 1
atggccagta tggataaggt ttttgcaggc tatgctgccc gtcaagcaat cttagaaagt 60
accgaaacta cgaacccgtt tgccaaagga attgcctggg tcgaagggga actcgttcct 120
ttagctgaag cacgcattcc actcctcgat cagggcttca tgcactccga tctgacctac 180
gacgtaccgt ctgtttggga tgggcgattt tttcgtttag atgatcatat tacacgcctg 240
gaagcaagct gcaccaagct gaggctgcgt ctacccttac cacgtgatca agttaaacaa 300
atcctggtgg aaatggtcgc aaaatctggt attcgggatg catttgttga attgatagtc 360
acccgcggtc ttaaaggggt gcgaggaact cgtccgcatg atatagtgaa caacctgtac 420
atgtttgtgc agccgtacgt gtgggttatg gagccggata tgcagcgcgt aggcggcagc 480
gcagtggtgg ctaggaccgt ccgccgggta ccaccgggcg ctattgatcc gaccgtcaag 540
aatcttcagt ggggtgatct tgttcgtgga atgtttgaag cggctgatcg tggcgcaaca 600
tatcccttcc ttaccgacgg cgatgcgcac ctgactgaag gatcgggttt taatatagta 660
ttagtcaaag atggcgtcct gtatacgcca gatcgcgggg tgctgcaggg agtgactcgc 720
aagtccgtta tcaacgctgc tgaagccttt ggaatagaag tgcgggttga gttcgttcca 780
gttgagctgg cctaccggtg tgacgagatt ttcatgtgca cgacggcggg tggcattatg 840
cctatcacaa cattggacgg tatgcctgta aatggtgggc aaattgggcc tattacgaaa 900
aaaatatggg acggttattg ggcgatgcat tatgacgccg cgtattcgtt cgagatcgac 960
tataatgaga gaaattag 978
<210> 2
<211> 326
<212> PRT
<213> 土曲霉(Aspergillus terreus)
<400> 2
Met Ala Ser Met Asp Lys Val Phe Ala Gly Tyr Ala Ala Arg Gln Ala
1 5 10 15
Ile Leu Glu Ser Thr Glu Thr Thr Asn Pro Phe Ala Lys Gly Ile Ala
20 25 30
Trp Val Glu Gly Glu Leu Val Pro Leu Ala Glu Ala Arg Ile Pro Leu
35 40 45
Leu Asp Gln Gly Phe Met His Ser Asp Leu Thr Tyr Asp Val Pro Ser
50 55 60
Val Trp Asp Gly Arg Phe Phe Arg Leu Asp Asp His Ile Thr Arg Leu
65 70 75 80
Leu Glu Ala Ser Cys Thr Lys Leu Arg Leu Arg Leu Pro Leu Pro Arg
85 90 95
Asp Gln Val Lys Gln Ile Leu Val Glu Met Val Ala Lys Ser Gly Ile
100 105 110
Arg Asp Ala Phe Val Glu Leu Ile Val Thr Arg Gly Leu Lys Gly Val
115 120 125
Arg Gly Thr Arg Pro Glu Asp Ile Val Asn Asn Leu Tyr Met Phe Val
130 135 140
Gln Pro Tyr Val Trp Val Met Glu Pro Asp Met Gln Arg Val Gly Gly
145 150 155 160
Ser Ala Val Val Ala Arg Thr Val Arg Arg Val Pro Pro Gly Ala Ile
165 170 175
Asp Pro Thr Val Lys Asn Leu Gln Trp Gly Asp Leu Val Arg Gly Met
180 185 190
Phe Glu Ala Ala Asp Arg Gly Ala Thr Tyr Pro Phe Leu Thr Asp Gly
195 200 205
Asp Ala His Leu Thr Glu Gly Ser Gly Phe Asn Ile Val Leu Val Lys
210 215 220
Asp Gly Val Leu Tyr Thr Pro Asp Arg Gly Val Leu Gln Gly Val Thr
225 230 235 240
Arg Lys Ser Val Ile Asn Ala Ala Glu Ala Phe Gly Ile Glu Val Arg
245 250 255
Val Glu Phe Val Pro Val Glu Leu Ala Tyr Arg Cys Asp Glu Ile Phe
260 265 270
Met Cys Thr Thr Ala Gly Gly Ile Met Pro Ile Thr Thr Leu Asp Gly
275 280 285
Met Pro Val Asn Gly Gly Gln Ile Gly Pro Ile Thr Lys Lys Ile Trp
290 295 300
Asp Gly Tyr Trp Ala Met His Tyr Asp Ala Ala Tyr Ser Phe Glu Ile
305 310 315 320
Asp Tyr Asn Glu Arg Asn
325
<210> 3
<211> 990
<212> DNA
<213> 土曲霉(Aspergillus terreus)
<400> 3
atggcgagca tggaaaaagt gtttgcgggc tatcaggcgc gccaggcggt gctggaagcg 60
agcgcgagca ccaacccgtt tgcgaaaggc attgcgtggg tggaaggcga actggtgccg 120
ctgcatgaag cgcgcattcc gctgctggat cagggcttta tgcatagcga tctgacctat 180
gatgtgccga gcgtgtggga tggccgcttt tttcgcctgg atgatcatct gagccgcctg 240
gaagcgagct gcagcaaaat gcgcctgaaa ctgccgctgc cgcgcgaaga agtgaaacag 300
attctggtgg atatggtggc gaaaagcggc attcgcgatg cgtttgtgga actgattgtg 360
acccgcggcc tgaaaggcgt gcgcggcagc aaaccggaag aactggtgaa caacaacctg 420
tatatgttta ttcagccgta tgtgtgggtg atggaaccgg aaatgcagcg caccggcggc 480
agcgcgatta ttgcgcgcac cgtgcgccgc gtgccgccgg gcagcatgga tccgaccgtg 540
aaaaacctgc agtggggcga tctgacccgc ggcatgtttg aagcgagcga tcgcggcgcg 600
acctatccgt ttctgaccga tggcgatgcg aacctgaccg aaggcagcgg ctttaacatt 660
gtgctggtga aagatggcgt gctgtatacc ccggatcgcg gcgtgctgga aggcgtgacc 720
cgcaaaagcg tgattgatgt ggcgcgcgcg aacggcattg aagtgcgcgt ggaagtggtg 780
ccggtggaac tggcgtatca gtgcgatgaa atttttatgt gcaccaccgc gggcggcatt 840
atgccgatta ccagcctgga tggcaaaccg gtgaacgatg gcaaagtggg cccgattacc 900
aaaaaaattt gggatggcta ttgggcgatg cattatgatc cggcgtatag ctttgaaatt 960
gattatgaaa gcgcgagcaa aaaaagcggc 990
<210> 4
<211> 330
<212> PRT
<213> 土曲霉(Aspergillus terreus)
<400> 4
Met Ala Ser Met Glu Lys Val Phe Ala Gly Tyr Gln Ala Arg Gln Ala
1 5 10 15
Val Leu Glu Ala Ser Ala Ser Thr Asn Pro Phe Ala Lys Gly Ile Ala
20 25 30
Trp Val Glu Gly Glu Leu Val Pro Leu His Glu Ala Arg Ile Pro Leu
35 40 45
Leu Asp Gln Gly Phe Met His Ser Asp Leu Thr Tyr Asp Val Pro Ser
50 55 60
Val Trp Asp Gly Arg Phe Phe Arg Leu Asp Asp His Leu Ser Arg Leu
65 70 75 80
Glu Ala Ser Cys Ser Lys Met Arg Leu Lys Leu Pro Leu Pro Arg Glu
85 90 95
Glu Val Lys Gln Ile Leu Val Asp Met Val Ala Lys Ser Gly Ile Arg
100 105 110
Asp Ala Phe Val Glu Leu Ile Val Thr Arg Gly Leu Lys Gly Val Arg
115 120 125
Gly Ser Lys Pro Glu Glu Leu Val Asn Asn Asn Leu Tyr Met Phe Ile
130 135 140
Gln Pro Tyr Val Trp Val Met Glu Pro Glu Met Gln Arg Thr Gly Gly
145 150 155 160
Ser Ala Ile Ile Ala Arg Thr Val Arg Arg Val Pro Pro Gly Ser Met
165 170 175
Asp Pro Thr Val Lys Asn Leu Gln Trp Gly Asp Leu Thr Arg Gly Met
180 185 190
Phe Glu Ala Ser Asp Arg Gly Ala Thr Tyr Pro Phe Leu Thr Asp Gly
195 200 205
Asp Ala Asn Leu Thr Glu Gly Ser Gly Phe Asn Ile Val Leu Val Lys
210 215 220
Asp Gly Val Leu Tyr Thr Pro Asp Arg Gly Val Leu Glu Gly Val Thr
225 230 235 240
Arg Lys Ser Val Ile Asp Val Ala Arg Ala Asn Gly Ile Glu Val Arg
245 250 255
Val Glu Val Val Pro Val Glu Leu Ala Tyr Gln Cys Asp Glu Ile Phe
260 265 270
Met Cys Thr Thr Ala Gly Gly Ile Met Pro Ile Thr Ser Leu Asp Gly
275 280 285
Lys Pro Val Asn Asp Gly Lys Val Gly Pro Ile Thr Lys Lys Ile Trp
290 295 300
Asp Gly Tyr Trp Ala Met His Tyr Asp Pro Ala Tyr Ser Phe Glu Ile
305 310 315 320
Asp Tyr Glu Ser Ala Ser Lys Lys Ser Gly
325 330
<210> 5
<211> 984
<212> DNA
<213> 土曲霉(Aspergillus terreus)
<400> 5
atggccagca tggaaaaagt gtttgccggt tatcaggccc gtcaggccgt tctggaagca 60
agcgcaagta ccaatccgtt tgcaaaaggc attgcctggg tggaaggcga actggttccg 120
ctgcatgaag cacgtattcc gctgctggat cagggcttta tgcatagtga tctgacctat 180
gatgttccga gcgtgtggga tggccgcttt ttccgtctgg atgatcatct gagtcgtctg 240
gaagcatcat gcgccaaact gcgcctgaaa ctgccgctgc cgcgtgaaga agttaaacag 300
attctggttg atatggtggc aaaaagtggt attcgtgatg catttgtgga actgattgtg 360
acccgcggcc tgaaaggtgt tcgtggtagc aaaccggaag atctggtgaa taataatctg 420
tatatgttca tccagccgta tgtgtgggtt atggaaccgg aagttcagcg caccggcggt 480
agcgccatta ttgcacgtac cgttcgtcgt gtgccgccgg gcgctattga tccgaccgtt 540
aaaaatctgc agtggggtga cctggttcgc ggcatgtttg aagccagcga tcgtggcgca 600
acctatccgt ttctgaccga tggtgacgca aatctgaccg aaggtagtgg ctttaatatt 660
gtgctggtga aagatggtgt tctgtatacc ccggatcgtg gcgttctgga aggcgtgacc 720
cgcaaaagtg tgattgatgt tgcacgcgcc aatggtattg aagtgcgcgt tgaagtggtg 780
ccggtggaaa tggcatatca gtgtgatgaa atttttatgt gcaccaccgc cggcggcatt 840
atgccgatta ccagtctgga tggtaaaccg gtgaatgatg gcaaagttgg cccgattacc 900
aaaaagattt gggatggcta ttgggccatg cattatgatc cggcatatag ttttgaaatt 960
gattatgaaa gcgcgagtaa aagt 984
<210> 6
<211> 328
<212> PRT
<213> 土曲霉(Aspergillus terreus)
<400> 6
Met Ala Ser Met Glu Lys Val Phe Ala Gly Tyr Gln Ala Arg Gln Ala
1 5 10 15
Val Leu Glu Ala Ser Ala Ser Thr Asn Pro Phe Ala Lys Gly Ile Ala
20 25 30
Trp Val Glu Gly Glu Leu Val Pro Leu His Glu Ala Arg Ile Pro Leu
35 40 45
Leu Asp Gln Gly Phe Met His Ser Asp Leu Thr Tyr Asp Val Pro Ser
50 55 60
Val Trp Asp Gly Arg Phe Phe Arg Leu Asp Asp His Leu Ser Arg Leu
65 70 75 80
Glu Ala Ser Cys Ala Lys Leu Arg Leu Lys Leu Pro Leu Pro Arg Glu
85 90 95
Glu Val Lys Gln Ile Leu Val Asp Met Val Ala Lys Ser Gly Ile Arg
100 105 110
Asp Ala Phe Val Glu Leu Ile Val Thr Arg Gly Leu Lys Gly Val Arg
115 120 125
Gly Ser Lys Pro Glu Asp Leu Val Asn Asn Asn Leu Tyr Met Phe Ile
130 135 140
Gln Pro Tyr Val Trp Val Met Glu Pro Glu Val Gln Arg Thr Gly Gly
145 150 155 160
Ser Ala Ile Ile Ala Arg Thr Val Arg Arg Val Pro Pro Gly Ala Ile
165 170 175
Asp Pro Thr Val Lys Asn Leu Gln Trp Gly Asp Leu Val Arg Gly Met
180 185 190
Phe Glu Ala Ser Asp Arg Gly Ala Thr Tyr Pro Phe Leu Thr Asp Gly
195 200 205
Asp Ala Asn Leu Thr Glu Gly Ser Gly Phe Asn Ile Val Leu Val Lys
210 215 220
Asp Gly Val Leu Tyr Thr Pro Asp Arg Gly Val Leu Glu Gly Val Thr
225 230 235 240
Arg Lys Ser Val Ile Asp Val Ala Arg Ala Asn Gly Ile Glu Val Arg
245 250 255
Val Glu Val Val Pro Val Glu Met Ala Tyr Gln Cys Asp Glu Ile Phe
260 265 270
Met Cys Thr Thr Ala Gly Gly Ile Met Pro Ile Thr Ser Leu Asp Gly
275 280 285
Lys Pro Val Asn Asp Gly Lys Val Gly Pro Ile Thr Lys Lys Ile Trp
290 295 300
Asp Gly Tyr Trp Ala Met His Tyr Asp Pro Ala Tyr Ser Phe Glu Ile
305 310 315 320
Asp Tyr Glu Ser Ala Ser Lys Ser
325
Claims (9)
1.一种基于祖先序列重建的ω-转氨酶突变体,其特征在于,由来自土曲霉(Aspergillus terreus)的ω-转氨酶突变所得,所述ω-转氨酶突变体的氨基酸序列如SEQID NO.4或SEQ ID NO.6所示。
2.如权利要求1所述ω-转氨酶突变体在催化(R)-(+)-α-甲基苄胺生成苯乙酮中的应用。
3.编码如权利要求1所述ω-转氨酶突变体的基因。
4.如权利要求3所述的基因,其特征在于,ω-转氨酶突变体的基因序列为SEQ ID NO.3或SEQ ID NO.5所示。
5.如权利要求3所述基因在催化(R)-(+)-α-甲基苄胺生成苯乙酮中的应用。
6.包含如权利要求3所述基因的重组表达质粒。
7.包含如权利要求6所述重组表达质粒的基因工程菌。
8.如权利要求7所述基因工程菌在催化(R)-(+)-α-甲基苄胺生成苯乙酮中的应用。
9.一种催化(R)-(+)-α-甲基苄胺生成苯乙酮的方法,其特征在于,以(R)-(+)-α-甲基苄胺和丙酮酸作为底物,使用权利要求1所述ω-转氨酶突变体或权利要求7所述基因工程菌进行催化发生转氨反应,生成苯乙酮。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111482472.1A CN114134128B (zh) | 2021-12-07 | 2021-12-07 | 一种基于祖先序列重建的ω-转氨酶突变体 |
PCT/CN2022/136528 WO2023103947A1 (zh) | 2021-12-07 | 2022-12-05 | 一种基于祖先序列重建的ω-转氨酶突变体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111482472.1A CN114134128B (zh) | 2021-12-07 | 2021-12-07 | 一种基于祖先序列重建的ω-转氨酶突变体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114134128A true CN114134128A (zh) | 2022-03-04 |
CN114134128B CN114134128B (zh) | 2023-05-23 |
Family
ID=80384774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111482472.1A Active CN114134128B (zh) | 2021-12-07 | 2021-12-07 | 一种基于祖先序列重建的ω-转氨酶突变体 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114134128B (zh) |
WO (1) | WO2023103947A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023103947A1 (zh) * | 2021-12-07 | 2023-06-15 | 浙江科技学院 | 一种基于祖先序列重建的ω-转氨酶突变体 |
WO2024146119A1 (zh) * | 2023-01-05 | 2024-07-11 | 山东省计算中心(国家超级计算济南中心) | 基于超级计算辅助获得d-氨基酸转氨酶突变体及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108913671A (zh) * | 2018-06-15 | 2018-11-30 | 浙江科技学院 | 一种ω-转氨酶突变体及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2599644T3 (es) * | 2009-09-02 | 2017-02-02 | Lonza Ag | Un proceso para la identificación y preparación de una omega-transaminasa (R)-específica |
CN110144335B (zh) * | 2019-04-26 | 2021-02-19 | 浙江科技学院 | 一种ω-转氨酶双突变体及其应用 |
CN116445445A (zh) * | 2020-11-26 | 2023-07-18 | 浙江科技学院 | 一种ω-转氨酶突变体及其应用 |
CN114181918B (zh) * | 2020-12-04 | 2023-09-15 | 浙江科技学院 | 一种通过DNA合成改组组合突变获得的ω-转氨酶突变体及应用 |
CN114134128B (zh) * | 2021-12-07 | 2023-05-23 | 浙江科技学院 | 一种基于祖先序列重建的ω-转氨酶突变体 |
-
2021
- 2021-12-07 CN CN202111482472.1A patent/CN114134128B/zh active Active
-
2022
- 2022-12-05 WO PCT/CN2022/136528 patent/WO2023103947A1/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108913671A (zh) * | 2018-06-15 | 2018-11-30 | 浙江科技学院 | 一种ω-转氨酶突变体及其应用 |
Non-Patent Citations (2)
Title |
---|
JIA-REN CAO ET AL.: "Improving the Thermostability and Activity of Transaminase From Aspergillus terreus by Charge-Charge Interaction", FRONTIERS IN CHEMISTRY | * |
谢东芳等: "删除Loop 区域表面不稳定氨基酸提高 (R)-ω-转氨 酶热稳定性", 生物工程学 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023103947A1 (zh) * | 2021-12-07 | 2023-06-15 | 浙江科技学院 | 一种基于祖先序列重建的ω-转氨酶突变体 |
WO2024146119A1 (zh) * | 2023-01-05 | 2024-07-11 | 山东省计算中心(国家超级计算济南中心) | 基于超级计算辅助获得d-氨基酸转氨酶突变体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114134128B (zh) | 2023-05-23 |
WO2023103947A1 (zh) | 2023-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109593750B (zh) | 一种腈水合酶突变体、含该突变体的基因工程菌及其应用 | |
CN114134128B (zh) | 一种基于祖先序列重建的ω-转氨酶突变体 | |
CN110229805B (zh) | 一种通过序列一致性制备的谷氨酸脱羧酶突变体及其应用 | |
WO2019169689A1 (zh) | 一种得到高表达、高活力及高稳定性的酶突变体的方法 | |
CN107201352B (zh) | 一种具有高转糖苷活性的β-半乳糖苷酶组合突变体及其制备方法和应用 | |
CN108913671B (zh) | 一种ω-转氨酶突变体及其应用 | |
CN107893060B (zh) | 一种海洋细菌来源热稳定耐盐sgnh家族水解酶及应用 | |
CN109971734B (zh) | 一种pH不敏感高温耐受性HSL家族脂类水解酶及应用 | |
CN111826362B (zh) | 一种ω-转氨酶突变体、基因及应用 | |
CN110144335B (zh) | 一种ω-转氨酶双突变体及其应用 | |
CN115717137B (zh) | 赖氨酰特异性内切酶突变体及其制备方法和应用 | |
CN112175980A (zh) | 通过定点突变提高聚合酶大片段活性的方法及应用 | |
CN112877307A (zh) | 一种氨基酸脱氢酶突变体及其应用 | |
CN113308453B (zh) | 酰胺水解酶SaAH及其编码基因和应用 | |
CN111139229A (zh) | 一种新型gdsl家族脂类水解酶eii-2及其编码基因与应用 | |
CN107779459B (zh) | 葡萄糖脱氢酶dna分子、载体和菌株及应用 | |
CN116121215A (zh) | 一种甘油磷酸氧化酶的突变体及其用途 | |
CN114277022A (zh) | 一种高活性和高热稳定性的腈水合酶突变体 | |
CN113699131A (zh) | 一种α-环糊精葡萄糖基转移酶突变体及其应用 | |
CN111607583A (zh) | 一种谷氨酸脱羧酶突变体、基因及应用 | |
CN110804602A (zh) | 一种L-天冬氨酸β-脱羧酶突变体及其应用 | |
JP3536049B2 (ja) | 変異型カナマイシンヌクレオチジルトランスフェラーゼ及びこれを用いた好熱菌のスクリーニング方法 | |
CN112760306B (zh) | 一种具有高盐度、有机溶剂及去垢剂高耐受性的第六家族酯类水解酶及其编码基因、应用 | |
CN113151210B (zh) | 一种高比酶活过氧化物酶突变体及其应用 | |
CN110229798B (zh) | 一种含硒蛋白及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240909 Address after: No. 1666, East Ring Road, Juancheng County, Heze City, Shandong Province 274699 Patentee after: SHANDONG YANGCHENG BIOTECH Co.,Ltd. Country or region after: China Address before: 310023 No. 318 stay Road, Xihu District, Zhejiang, Hangzhou Patentee before: ZHEJIANG University OF SCIENCE AND TECHNOLOGY Country or region before: China |
|
TR01 | Transfer of patent right |